GSK asks US patent office to refuse Moderna’s ‘Covid Mvax’ trademark registration as ‘too generic’

Before there were Covid-19 vaccines, there were trademarked names for Covid-19 vaccines. The pharma companies working fast and furiously on the scientific discoveries in 2020 also deployed marketing teams and branding agencies to come up with potential vaccine names.

Pfizer and BioNtech, Moderna, Johnson & Johnson and Novavax all filed multiple potential names with the US Patent and Trademark Office in 2020 and early 2021.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and

November 20, 2023

Recognizing and acting on heart attack symptoms linked to faster treatment, better outcomes

Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according to research presented at ESC Congress 2023.

August 22, 2023

Federal judge rules against Philadelphia supervised drug consumption effort

A federal judge this week dealt a major and likely decisive blow to Safehouse, a Philadelphia nonprofit seeking to open a facility for supervised drug

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.